Literature DB >> 25667418

Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus.

Marcel Costa-Garcia1, Andrea Vera1, Manuela Moraru2, Carlos Vilches2, Miguel López-Botet3, Aura Muntasell4.   

Abstract

Human CMV (HCMV) infection promotes a variable and persistent expansion of functionally mature NKG2C(bright) NK cells. We analyzed NKG2C(bright) NK cell responses triggered by Abs from HCMV(+) sera against HCMV-infected MRC5 fibroblasts. Specific Abs promoted the degranulation (i.e., CD107a expression) and the production of cytokines (TNF-α and IFN-γ) by a significant fraction of NK cells, exceeding the low natural cytotoxicity against HCMV-infected targets. NK cell-mediated Ab-dependent cell-mediated cytotoxicity was limited by viral Ag availability and HLA class I expression on infected cells early postinfection and increased at late stages, overcoming viral immunoevasion strategies. Moreover, the presence of specific IgG triggered the activation of NK cells against Ab-opsonized cell-free HCMV virions. As compared with NKG2A(+) NK cells, a significant proportion of NKG2C(bright) NK cells was FcεR γ-chain defective and highly responsive to Ab-driven activation, being particularly efficient in the production of antiviral cytokines, mainly TNF-α. Remarkably, the expansion of NKG2C(bright) NK cells in HCMV(+) subjects was related to the overall magnitude of TNF-α and IFN-γ cytokine secretion upon Ab-dependent and -independent activation. We show the power and sensitivity of the anti-HCMV response resulting from the cooperation between specific Abs and the NKG2C(bright) NK-cell subset. Furthermore, we disclose the proinflammatory potential of NKG2C(bright) NK cells, a variable that could influence the individual responses to other pathogens and tumors.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25667418     DOI: 10.4049/jimmunol.1402281

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies.

Authors:  Letizia Muccio; Alice Bertaina; Michela Falco; Daniela Pende; Raffaella Meazza; Miguel Lopez-Botet; Lorenzo Moretta; Franco Locatelli; Alessandro Moretta; Mariella Della Chiesa
Journal:  Haematologica       Date:  2015-12-11       Impact factor: 9.941

Review 2.  The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

Authors:  Frank Cichocki; Michael R Verneris; Sarah Cooley; Veronika Bachanova; Claudio G Brunstein; Bruce R Blazar; John Wagner; Heinrich Schlums; Yenan T Bryceson; Daniel J Weisdorf; Jeffrey S Miller
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

3.  Impact of Zygosity on Bimodal Phenotype Distributions.

Authors:  Thomas Holst-Hansen; Elena Abad; Aura Muntasell; Miguel López-Botet; Mogens H Jensen; Ala Trusina; Jordi Garcia-Ojalvo
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

Review 4.  Cytomegalovirus: an unlikely ally in the fight against blood cancers?

Authors:  A B Bigley; F L Baker; R J Simpson
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

5.  Specificity and effector functions of non-neutralizing gB-specific monoclonal antibodies isolated from healthy individuals with human cytomegalovirus infection.

Authors:  Matthew L Goodwin; Helen S Webster; Hsuan-Yuan Wang; Jennifer A Jenks; Cody S Nelson; Joshua J Tu; Jesse F Mangold; Sarah Valencia; Justin Pollara; Whitney Edwards; Jason S McLellan; Daniel Wrapp; Tong-Ming Fu; Ningyan Zhang; Daniel C Freed; Dai Wang; Zhiqiang An; Sallie R Permar
Journal:  Virology       Date:  2020-07-22       Impact factor: 3.616

6.  Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control.

Authors:  Annelise Y Mah; Armin Rashidi; Molly P Keppel; Nermina Saucier; Emily K Moore; Joshua B Alinger; Sandeep K Tripathy; Sandeep K Agarwal; Emily K Jeng; Hing C Wong; Jeffrey S Miller; Todd A Fehniger; Emily M Mace; Anthony R French; Megan A Cooper
Journal:  JCI Insight       Date:  2017-12-07

7.  Modification of NK cell subset repartition and functions in granulocyte colony-stimulating factor-mobilized leukapheresis after expansion with IL-15.

Authors:  Yu Xiong; Manon Mouginot; Loic Reppel; Chongsheng Qian; Jean-Francois Stoltz; Danièle Bensoussan; Véronique Decot
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

8.  PD-1 Expression on NK Cells in Malaria-Exposed Individuals Is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity.

Authors:  Jacqueline Moebius; Rajan Guha; Mary Peterson; Kaveh Abdi; Jeff Skinner; Shanping Li; Gunjan Arora; Boubacar Traore; Sumati Rajagopalan; Eric O Long; Peter D Crompton
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

9.  Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.

Authors:  Costin Tomescu; Kyle Kroll; Krystal Colon; Emmanouil Papasavvas; Ian Frank; Pablo Tebas; Karam Mounzer; Roger Keith Reeves; Luis J Montaner
Journal:  Eur J Immunol       Date:  2021-06-19       Impact factor: 6.688

10.  CD56dim CD57- NKG2C+ NK cells retaining proliferative potential are possible precursors of CD57+ NKG2C+ memory-like NK cells.

Authors:  Polina A Kobyzeva; Maria A Streltsova; Sofya A Erokhina; Leonid M Kanevskiy; William G Telford; Alexander M Sapozhnikov; Elena I Kovalenko
Journal:  J Leukoc Biol       Date:  2020-09-15       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.